Literature DB >> 10508039

Potent bacteriolytic activity of ritipenem associated with a characteristic profile of affinities for penicillin-binding proteins of Haemophilus influenzae.

T Inui1, T Oshida, T Endo, T Matsushita.   

Abstract

Ritipenem is highly bacteriolytic against Haemophilus influenzae. Bacterial lysis was shown after treatments with ritipenem and cefsulodin at their MICs and after treatments with fropenem and cefdinir at four times their MICs, indicated by decreases in the culture turbidities and by morphological changes of the destroyed cells. These beta-lactams were preferentially bound to penicillin-binding protein (PBP) 1b. Ritipenem, fropenem, and cefsulodin exhibited poor affinities to PBPs 3a and 3b, but cefdinir showed high affinities to these PBPs. Microscopic examinations revealed that selective PBP 3 inhibitors, such as aztreonam and cefotaxime, inhibited lysis induced by ritipenem. These results suggest that the preferential inactivation of PBP 1b could be essential to induce the lysis of H. influenzae cells and that binding to PBPs 3a and 3b may interfere with lysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508039      PMCID: PMC89515          DOI: 10.1128/AAC.43.10.2534

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Synthesis and antimicrobial spectrum of FCE 22101 and its orally available ester FCE 22891.

Authors:  G Franceschi; E Perrone; M Alpegiani; A Bedeschi; C Battistini; F Zarini; C Della Bruna
Journal:  J Antimicrob Chemother       Date:  1989-03       Impact factor: 5.790

2.  In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.

Authors:  K Dornbusch; G Kronvall; E Göransson; E Mörtsell
Journal:  J Antimicrob Chemother       Date:  1989-03       Impact factor: 5.790

3.  Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland.

Authors:  R Manninen; P Huovinen; A Nissinen
Journal:  J Antimicrob Chemother       Date:  1997-09       Impact factor: 5.790

4.  Properties of the penicillin-binding proteins of Escherichia coli K12,.

Authors:  B G Spratt
Journal:  Eur J Biochem       Date:  1977-01

5.  Thermosensitive mutation in Escherichia coli simultaneously causing defects in penicillin-binding protein-1Bs and in enzyme activity for peptidoglycan synthesis in vitro.

Authors:  S Tamaki; S Nakajima; M Matsuhashi
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 6.  Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection.

Authors:  T F Murphy; M A Apicella
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

7.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

8.  Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada.

Authors:  N Clairoux; M Picard; A Brochu; N Rousseau; P Gourde; D Beauchamp; T R Parr; M G Bergeron; F Malouin
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

9.  Haemophilus influenzae penicillin-binding proteins 1a and 3 possess distinct and opposite temperature-modulated penicillin-binding activities.

Authors:  F Malouin; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

10.  The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.

Authors:  H C Neu; N X Chin; P Labthavikul
Journal:  J Antimicrob Chemother       Date:  1985-09       Impact factor: 5.790

View more
  1 in total

1.  Morphological changes and lysis induced by beta-lactams associated with the characteristic profiles of affinities of penicillin-binding proteins in actinobacillus pleuropneumoniae.

Authors:  T Inui; T Endo; T Matsushita
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.